Burcon NutraScience (BRCN) Financials
$0.35
$-0.07
(-15.83%)
As on 11-Nov-2022 09:30EDT
Market cap
$47 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
2.5
Div. Yield
0 %
Cashflow (CA$ Mln) |
TTM | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-5.91
|
-3.03
|
-3.37
|
-4.15
|
-4.62
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-1.23
|
-2.72
|
-14.49
|
-0.02
|
-0.02
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
0.17
|
4.70
|
32.40
|
1.23
|
3.38
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (CA$)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash EPS (CA$)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Adjusted Book Value (CA$)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Dividend per Share (CA$)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share (CA$)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Free Cash Flow per Share (CA$)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-31.80
|
-2.09
|
-44.20
|
-2,618.30
|
-479.55
|
|
|
|
|
|
|
ROE (%)
|
-39.30
|
-31.80
|
-2.09
|
-44.20
|
-2,618.30
|
-239.78
|
|
|
|
|
|
|
ROA (%)
|
-35.23
|
-30.59
|
-1.79
|
-27.47
|
-120.91
|
-103.38
|
|
|
|
|
|
|
EBIT Margin (%)
|
-3,300.92
|
-4,512.57
|
-1,877.56
|
-11,958.40
|
-11,330.30
|
-11,403.94
|
|
|
|
|
|
|
Net Margin (%)
|
-4,537.20
|
-5,982.59
|
-238.74
|
-14,882.42
|
-11,890.83
|
-11,471.79
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
-0.03
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-8.97
|
-0.34
|
7.31
|
-0.23
|
-0.18
|
--
|
|
|
|
|
|
|
EBIT Growth (%)
|
-40.84
|
-59.34
|
-30.43
|
18.21
|
18.56
|
--
|
|
|
|
|
|
|
Net Profit Growth (%)
|
-361.63
|
-1,561.30
|
86.67
|
3.01
|
15.04
|
--
|
|
|
|
|
|
|
EPS Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Current Ratio
|
3.16
|
7.30
|
10.09
|
9.91
|
0.21
|
4.41
|
|
|
|
|
|
|
Quick Ratio
|
3.16
|
7.30
|
10.00
|
9.83
|
--
|
--
|
|
|
|
|
|
|
Interest Coverage
|
-103.62
|
-106.69
|
-6.30
|
-6.32
|
-14.04
|
--
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
106.05
|
116.84
|
130.96
|
1,067.15
|
315.12
|
314.79
|
|
|
|
|
|
|
Asset Turnover
|
0.01
|
0.01
|
0.01
|
0.00
|
0.01
|
0.01
|
|
|
|
|
|
|
Receivable days
|
--
|
574.12
|
473.75
|
2,691.53
|
1,276.81
|
1,184.70
|
|
|
|
|
|
|
Inventory Days
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Payable days
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
